These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 9156369)
1. New dimensions in the pharmacologic treatment of schizophrenia and related psychoses. Buckley PF J Clin Pharmacol; 1997 May; 37(5):363-78. PubMed ID: 9156369 [TBL] [Abstract][Full Text] [Related]
2. Psychopharmacologic treatment of psychosis in children and adolescents: efficacy and management. Kranzler HN; Cohen SD Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):727-44. PubMed ID: 24012083 [TBL] [Abstract][Full Text] [Related]
3. New antipsychotic medications: what advantages do they offer? Citrome L Postgrad Med; 1997 Feb; 101(2):207-10, 213-4. PubMed ID: 9046936 [TBL] [Abstract][Full Text] [Related]
8. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Fulton B; Goa KL Drugs; 1997 Feb; 53(2):281-98. PubMed ID: 9028746 [TBL] [Abstract][Full Text] [Related]
9. New antipsychotics and schizophrenia: a review on efficacy and side effects. Serretti A; De Ronchi D; Lorenzi C; Berardi D Curr Med Chem; 2004 Feb; 11(3):343-58. PubMed ID: 14965236 [TBL] [Abstract][Full Text] [Related]
10. Olanzapine: an updated review of its use in the management of schizophrenia. Bhana N; Foster RH; Olney R; Plosker GL Drugs; 2001; 61(1):111-61. PubMed ID: 11217867 [TBL] [Abstract][Full Text] [Related]
12. Novel antipsychotics and patient care in state hospitals. Buckley PF Ann Pharmacother; 1998 Sep; 32(9):906-14. PubMed ID: 9762379 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological management of first-episode schizophrenia and related nonaffective psychoses. Bradford DW; Perkins DO; Lieberman JA Drugs; 2003; 63(21):2265-83. PubMed ID: 14524730 [TBL] [Abstract][Full Text] [Related]
14. Pimozide for schizophrenia or related psychoses. Mothi M; Sampson S Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433 [TBL] [Abstract][Full Text] [Related]
15. Treatment of psychosis: 30 years of progress. De Oliveira IR; Juruena MF J Clin Pharm Ther; 2006 Dec; 31(6):523-34. PubMed ID: 17176358 [TBL] [Abstract][Full Text] [Related]
16. Drugs for psychotic disorders. Treat Guidel Med Lett; 2010 Aug; 8(96):61-4; quiz two pages following last numbered page.. PubMed ID: 20651640 [No Abstract] [Full Text] [Related]
17. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study. Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371 [TBL] [Abstract][Full Text] [Related]
18. Risperidone versus other atypical antipsychotic medication for schizophrenia. Gilbody SM; Bagnall AM; Duggan L; Tuunainen A Cochrane Database Syst Rev; 2000; (3):CD002306. PubMed ID: 10908551 [TBL] [Abstract][Full Text] [Related]
19. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. Kane JM; Leucht S; Carpenter D; Docherty JP; J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142 [TBL] [Abstract][Full Text] [Related]
20. Men and women respond differently to antipsychotic drugs. Seeman MV Neuropharmacology; 2020 Feb; 163():107631. PubMed ID: 31077728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]